Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Novartis milestones be proud ! Management take a bow !
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 3970844"]From: Reuters</p><p>Published March 13, 2008 02:51 PM</p><p><br /></p><p>Novartis sued in Calif. over kids' cough medicine</p><p>Drugmakers recall infant cold medicine</p><p><br /></p><p>FDA warns against cold drugs for kids under 2</p><p>January 17, 2008 07:06 PM</p><p><br /></p><p> LOS ANGELES (Reuters) - A California mother has sued drug maker Novartis AG in what the company believes to be the first proposed class action involving its Triaminic children's cough and cold medicines since overdose fears prompted a recall of the drugs.</p><p> The lawsuit, filed on Tuesday in U.S. District Court in Los Angeles, said several studies have shown deaths and serious injuries linked to over-the-counter children's cold remedies.</p><p> As a result, Novartis "either knew ... or reasonably should have known that their cough and cold products were ineffective and dangerous when used by children under the age of six," the lawsuit said.</p><p><br /></p><p><br /></p><p><br /></p><p>Pfizer sues Novartis over Vfend antifungal patents</p><p> Fri Jan 7, 2011 10:13am EST </p><p>* Novartis' Sandoz unit alleged to infringe two patents</p><p>* Vfend sales $595 mln over nine months</p><p>By Jonathan Stempel</p><p><br /></p><p>NEW YORK, Jan 7 (Reuters) - Pfizer Inc (PFE.N) has sued Novartis AG's (NOVN.VX) Sandoz unit, accusing it of infringing its U.S. patents related to the antifungal treatment Vfend.</p><p><br /></p><p>Friday's complaint alleges that Sandoz is seeking permission from the U.S. Food and Drug Administration to sell a generic version of Vfend before the expiration of two patents issued in 1994 and 2003, respectively.</p><p><br /></p><p>Pfizer said an infringement will cause irreparable injury, according to the complaint filed with the U.S. district court in Wilmington, Delaware. It seeks to block Sandoz from selling any version of Vfend before the patents expire.</p><p><br /></p><p>A spokeswoman for Novartis did not immediately return requests for[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 3970844"]From: Reuters Published March 13, 2008 02:51 PM Novartis sued in Calif. over kids' cough medicine Drugmakers recall infant cold medicine FDA warns against cold drugs for kids under 2 January 17, 2008 07:06 PM LOS ANGELES (Reuters) - A California mother has sued drug maker Novartis AG in what the company believes to be the first proposed class action involving its Triaminic children's cough and cold medicines since overdose fears prompted a recall of the drugs. The lawsuit, filed on Tuesday in U.S. District Court in Los Angeles, said several studies have shown deaths and serious injuries linked to over-the-counter children's cold remedies. As a result, Novartis "either knew ... or reasonably should have known that their cough and cold products were ineffective and dangerous when used by children under the age of six," the lawsuit said. Pfizer sues Novartis over Vfend antifungal patents Fri Jan 7, 2011 10:13am EST * Novartis' Sandoz unit alleged to infringe two patents * Vfend sales $595 mln over nine months By Jonathan Stempel NEW YORK, Jan 7 (Reuters) - Pfizer Inc (PFE.N) has sued Novartis AG's (NOVN.VX) Sandoz unit, accusing it of infringing its U.S. patents related to the antifungal treatment Vfend. Friday's complaint alleges that Sandoz is seeking permission from the U.S. Food and Drug Administration to sell a generic version of Vfend before the expiration of two patents issued in 1994 and 2003, respectively. Pfizer said an infringement will cause irreparable injury, according to the complaint filed with the U.S. district court in Wilmington, Delaware. It seeks to block Sandoz from selling any version of Vfend before the patents expire. A spokeswoman for Novartis did not immediately return requests for[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Novartis milestones be proud ! Management take a bow !
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Novartis milestones be proud ! Management take a bow !
>